GlassScriptPhysician profile
Amanda O Murphy
NPI 1497754279
$769.00
in general payments reported to CMS, 2019-2025
16 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.41 · 2022: $124 · 2023: $190 · 2024: $240 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $271.92 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $117.92 | 2022-2024 | Jornay Pm |
| Seqirus USA INC | $67.07 | 2022-2023 | Flucelvax Quadrivalent |
| Mylan Specialty L.P. | $53.58 | 2021-2022 | |
| Sanofi Pasteur INC. | $32.24 | 2025 | |
| Tris Pharma INC | $31.04 | 2023-2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $30.04 | 2025 | Jornay Pm |
| Jazz Pharmaceuticals INC. | $24.42 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.21 | 2023 | Flumist Quadrivalent |
| Biomarin Pharmaceutical INC. | $20.51 | 2024 | Voxzogo 1.2mg |
| Qiagen, LLC | $19.39 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $17.75 | 2024 | Crysvita |
| Pfizer INC. | $15.80 | 2025 | |
| Verrica Pharmaceuticals INC. | $15.55 | 2024 | Ycanth |
| Supernus Pharmaceuticals, INC. | $14.72 | 2023 | Qelbree |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.